• Customer Service
    • Report A Claim
    • Renew Your Policy
    • Payment Receipt
    • Premium Paid Certificate
    • Fund Statement
    • Register for E-Nach
    • Claim Tracking
    • Register Complaint
    • Update FATCA/CRS
    • Update Contact Detail
    • Unclaimed Amount
    • Contact Us
    • NB Payment Link
  • Our Products
    • Edelweiss Tokio Life – Premier Guaranteed Income – A guaranteed income plan

    • Edelweiss Tokio Life – Wealth Secure+ – A new generation ULIP

    • Edelweiss Tokio Life – Wealth Plus – A savings and investment plan

    • Edelweiss Tokio Life – Zindagi Plus – A comprehensive term plan

    • All Products
  • Resume Application
  • Blogs
  • Knowledge Center
    • Life Insurance
    • Term Insurance
    • Unit Linked Insurance Plans
    • Retirement Insurance
    • Health Insurance Plans
    • Child Plans
    • Covid Insurance
    • NRI Insurance
    • Investment Plans
    • Endowment Plans
    • Group Insurance
    • Micro Insurance
    • Sabse Phele Life Insurance
    • Income Tax
  • About Us
    • Why Choose Us
    • Public Disclosure
    • Awards & Recognition
    • Testimonials
    • Our Funds
    • Careers
  • Login
    • Customer Login
    • Partner Login
  • Icon
    • FOR CUSTOMER SERVICE
      ( 8 AM TO 11 PM)
      1800 2121 212
      FOR PRODUCT QUERIES
      ( Give a missed call on )
      022 6611 6040
      • Customer Login
      • Partner Login
    Icon
    Icon

    Thank You!!

    Icon

    Error Message!

    Error

    Icon

    Error Message!

    Error

    In the News

    With Insurance, battle against Cancer half won

    11 February 2019

    NEW DELHI: Cancer is a life-threatening disease and its treatment continues to remain one of the most expensive, impacting one’s finances. A study by International Institute of Population Sciences found that two out of five cancer patients in India have to sell assets and incur debts to treat cancer.  

    Another study released recently by Edelweiss Tokio Life Insurance notes that half of the patients who are diagnosed with cancer are uninsured. Almost 50 per cent of them pay out of their pockets for treatment. About 92 per cent of the 100 oncologists who were surveyed in the study believe that a majority of patients discontinue treatment due to unaffordability.

    The study adds that nearly 75 per cent patients are either uninsured or are inadequately insured to pay for cancer care. “The financial impact of cancer is glaring. While there are advanced treatments available, the staggering cost involved makes it unaffordable for several patients,” said Sumit Rai, MD & CEO, Edelweiss Tokio.

    Cost of treatment

    There is no standard price tag for cancer cure. It can cost as low as Rs 2.5 lakh for six months of treatment with some of the lowest priced generic drugs, to as high as Rs 35 lakh.

     

    Edelweiss Tokio notes that currently, standard cancer treatment for early and locally advanced stages costs about Rs 4.5 lakh, and for metastatic stage cancer, about Rs 6 lakh. The financial burden increases sharply if a patient opts for advanced therapy. Across all cancer types, advanced therapy costs about Rs 10 lakh for locally advanced stage (stages 2 & 3) and about Rs 14 lakh for metastatic stage.

    According to Anand Prabhudesai, co-founder, Turtlemint, the major reasons why cancer treatment is so expensive are the astronomical cost of equipment and drugs. He said that setting up a cancer hospital can cost close to Rs 100 crore and each equipment that needs to be imported costs a small fortune.

    Once the treatment begins, every chemotherapy cycle costs Rs 63,500 - Rs 1.9 lakh; breast cancer surgery costs Rs 1.9-4.25 lakh; prostrate cancer surgery costs Rs 3.49-6.35 lakh. Breast cancer drugs cost around Rs 75,000 for each course; drugs for kidney and lung cancer cost around Rs 1 lakh. The treatment involves multiple courses and cycles.

    Why you should be worried

    A vast majority of doctors surveyed in the Edelweiss Tokio study believed that cancer incidences will rise by 23 per cent in the coming five years. While survival rates will drop as cancer condition progresses, cost of treatment increases significantly. This leads to several patients dropping out of the treatment routine. According to the Indian Council of Medical Research, breast, cervical, oral, lung and colorectal cancers contribute to a greater proportion of incidences, accounting for 47 per cent of all cancer cases.

    Meeting the cost

    Prabhudesai said that the cost of treatment of diseases, cancer in particular, needs more in-depth financial planning. “This is where insurance plays a key role. It not only meets diagnosis and treatment costs, but also prevents depletion of savings and incurrence of debts.” 

    Currently, critical illness insurance policy and standalone cancer insurance policy provide coverage for cancer, the sum of which can go as high as Rs 60 lakh. The standard health insurance policies also cover cancer, but not the total treatment cost.

    0

      Top Press Release

      #news

      A tech solution to the fraud conundrum

      04 Apr 2022

      15
      #news

      First time buying life insurance? Here’s what you should know

      08 Feb 2022

      18
      #news

      Govt’s focus on ‘Digital’ paves way for new India

      05 Feb 2022

      13
      #news

      Big trends that will define marketing in 2022

      23 Jan 2022

      10
      #news

      Five trends that will shape the life insurance

      15 Jan 2022

      8
      #news

      Before and After Covid

      01 Jan 2022

      9
      #news

      Step-by-Step approach to retirement planning

      29 Dec 2021

      14
      #news

      Limited pay for an unlimited future with Edelweiss Tokio Life–Total Protect Plus

      12 Dec 2021

      17
      #news

      How much life insurance cover does one need

      27 Nov 2021

      13
      #news

      PRs perception problem

      17 Nov 2021

      8
      • About Edelweiss Tokio
      • All Plans
      • Customer Service
      • Legal
      • Support
      • About Edelweiss Tokio

        • About Us
        • Board of Directors, Committees and Resignations
        • Key Management Persons
        • Edelweiss Tokio Life CSR Policy
        • Terms and conditions of appointment of the Independent Directors
        • Testimonials
        • Customer Advisory
        • Our funds
        • Become An Advisor
        • The Buzz
        • Notice & Scrutiniser Reports
        • Careers
        • Sitemap
        • Whistle Blower Policy
        • Remuneration Policy
        • Annual Return
        • Awards & Recognition
        • Branch List
      • All Plans

        • Term Insurance Plan
        • Term Insurance Plans - Hindi
        • Unit Linked Insurance Plans
        • Investment Plans
        • Child Insurance Plans
        • Retirement Insurance Plans
        • Retirement Insurance Plans - Hindi
        • Group Insurance Plans
        • Endowment Plans
        • Micro Insurance Plans
        • Sabse Pehle Life Insurance
        • Life Insurance Plan
        • NRI Insurance Plan
        • COVID-19 Insurance Plan
        • Health Insurance Plan
      • Customer Service

        • Service Parameters & TAT
        • Renew Online
        • Riders
        • E-Statements
        • NAVs
        • Grievance Redressal
        • Products and Riders
        • Unclaimed Amount
        • Payment options
        • Account Value Declaration
        • Fund history
        • Application Tracker
        • NB Payment Link
      • Legal

        • Terms & Conditions
        • Privacy Policy
        • Chat Policy
        • Fund Benchmark
        • Email Disclaimer
        • Institutional Disclaimer
        • Insurance Disclaimer
      • Group Companies

        • Edelweiss Financial Services Limited
        • Tokio Marine Holdings Inc.
      • Support

        • File A Complaint
        • Live Chat
        • Call Back
        • FAQ
        • Pre-sales process
        • Contact Us
      • Important Links

        • IRDAI
        • Life Insurance Council
        • Insurance Ombudsman
        • Anti Fraud Policy
        • Public Disclosure
        • Premium Calculator
        • Do Not Call Registry
        • Corporate Agents
        • Discontinued Products & Riders
        • Bonus Rates
        • Public Disclosure-Agent List
        • Goods and Services Tax
        • Consumer Education
        • Pre-Sales Process
        • Downloads
        • Terminated agents
        • IRDAI on Spurious Call
        • Electronic Insurance Account
        • mVikram
        • Edelweiss Tokio CSR Policy
        • T&C of Appointment of ID
        • Proposal Forms
        • Notice on cash collection
        • Compounding Calculator
        • Retirement Calculator
        • Income Tax
        • UW Philosophy for PLHA
        • UW Philosophy for Disability / Mental Illness
        • UW Philosophy for Transgender Persons
        • Organ Donation
        • Simplified Claim Process
      Registered & Corporate Office: 6th Floor, Tower 3, Wing ‘B’, Kohinoor City, Kirol Road, Kurla (W), Mumbai – 400070
      T: 1800-212-1212 F: (022) 6117 7833care@edelweisstokio.in https://www.edelweisstokio.in

      Edelweiss Tokio Life Insurance Company Limited. All Rights Reserved. Registered with Insurance Regulatory & Development Authority of India (IRDAI) as Life Insurance Company. IRDAI Regn. No.: 147. CIN: U66010MH2009PLC197336. Tax benefits are as per the Income Tax Act, 1961, and are subject to amendments made thereto from time to time. For more details on risk factors and terms and conditions, please read sales brochure carefully before concluding a sale. Flower & Edelweiss (as displayed above) are trademarks of Edelweiss Financial Services Limited; "Tokio" is Trademark of Tokio Marine Holdings Inc. and used by Edelweiss Tokio Life Insurance Co. Ltd. under license. Edelweiss Tokio Life Insurance Company Limited. Registered & Corporate Office: 6th Floor, Tower 3, Wing ‘B’, Kohinoor City, Kirol Road, Kurla (W), Mumbai – 400070.  Toll Free No.: 1800 212 1212 | Fax No.: +91 22 6117 7833 | www.edelweisstokio.in This is a Private website owned by the Company. Unauthorized scanning of vulnerabilities and exploitation of the same is strictly prohibited. If you have been found to do so, Company may bring Civil and/or Criminal action and/or legal proceedings against you which shall be entirely at your costs and consequences.

      BEWARE OF SPURIOUS PHONE CALLS AND FICTITIOUS/ FRAUDULENT OFFERS

      IRDAI is not involved in activities like selling insurance policies, announcing bonus or investment of premiums. Public receiving such phone calls are requested to lodge a police complaint.

      Copyright © 2019 Edelweiss Tokio Life Insurance Company Limited. All rights reserved.
      • Term of Service
      • Privacy Policy
      • Term of Service
      • Privacy Policy